These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 8998906

  • 41. Angiotensin II antagonists: a new class of antihypertensive agent.
    Waeber B, Brunner HR.
    Br J Clin Pract; 1996; 50(5):265-8. PubMed ID: 8794603
    [Abstract] [Full Text] [Related]

  • 42. [Losartan. The first non-peptide angiotensin II receptor antagonist for treatment of hypertension].
    Ibsen H, Rasmussen S, Slatanach R.
    Ugeskr Laeger; 1996 Jun 24; 158(26):3798-802. PubMed ID: 8686080
    [No Abstract] [Full Text] [Related]

  • 43. Angiotensin receptor antagonists as a treatment for hypertension.
    MacFadyen RJ, Reid JL.
    J Hypertens; 1994 Dec 24; 12(12):1333-8. PubMed ID: 7706690
    [No Abstract] [Full Text] [Related]

  • 44. Modulators of the renin-angiotensin-aldosterone system and cough in childhood.
    Donati-Genet P, Bianchetti MG.
    Pediatr Nephrol; 1996 Aug 24; 10(4):545-6. PubMed ID: 8865265
    [No Abstract] [Full Text] [Related]

  • 45. Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.
    Schmidt B, Schieffer B.
    J Med Chem; 2003 Jun 05; 46(12):2261-70. PubMed ID: 12773029
    [No Abstract] [Full Text] [Related]

  • 46. Angiotensin II receptor antagonists: the prototype losartan.
    Schaefer KL, Porter JA.
    Ann Pharmacother; 1996 Jun 05; 30(6):625-36. PubMed ID: 8792950
    [Abstract] [Full Text] [Related]

  • 47. Angiotensin II receptors and potassium channels: targets for new cardiovascular drugs.
    Barber DA, Barber CH, Bivins CL, Tackett RL.
    J Pract Nurs; 1995 Mar 05; 45(1):32-9; quiz 40-2. PubMed ID: 7714840
    [No Abstract] [Full Text] [Related]

  • 48. Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits the binding of N-formylmethionyl-leucyl-phenylalanine to neutrophil receptors.
    Raiden S, Giordano M, Andonegui G, Trevani AS, López DH, Nahmod V, Geffner JR.
    J Pharmacol Exp Ther; 1997 May 05; 281(2):624-8. PubMed ID: 9152365
    [Abstract] [Full Text] [Related]

  • 49. Angiotensin receptors and their therapeutic implications.
    Griendling KK, Lassègue B, Alexander RW.
    Annu Rev Pharmacol Toxicol; 1996 May 05; 36():281-306. PubMed ID: 8725391
    [Abstract] [Full Text] [Related]

  • 50. Losartan does not influence the blood platelet aggregation in normotensive rats.
    Chabielska E, Pawlak R, Buczko W.
    Acta Physiol Hung; 1996 May 05; 84(3):271-2. PubMed ID: 9219602
    [Abstract] [Full Text] [Related]

  • 51. Angiotensin II receptor blockers. A new class of antihypertensive drugs.
    Velasquez MT.
    Arch Fam Med; 1996 Jun 05; 5(6):351-6. PubMed ID: 8640326
    [Abstract] [Full Text] [Related]

  • 52. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
    Burnier M, Brunner HR.
    Exp Nephrol; 1996 Jun 05; 4 Suppl 1():41-6. PubMed ID: 9001896
    [Abstract] [Full Text] [Related]

  • 53. How well have animal studies with losartan predicted responses in humans?
    Sweet CS, Nelson EB.
    J Hypertens Suppl; 1993 Apr 05; 11(3):S63-7. PubMed ID: 8315522
    [Abstract] [Full Text] [Related]

  • 54. Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study.
    Nielsen S, Dollerup J, Nielsen B, Jensen HA, Mogensen CE.
    Nephrol Dial Transplant; 1997 Apr 05; 12 Suppl 2():19-23. PubMed ID: 9269694
    [Abstract] [Full Text] [Related]

  • 55. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
    Goldberg MR, Lo MW, Christ DD, Chiou R, Furtek CI, Amit O, Carides A, Biollaz J, Piguet V, Nussberger J, Brunner HR.
    Clin Pharmacol Ther; 1997 Jan 05; 61(1):59-69. PubMed ID: 9024174
    [Abstract] [Full Text] [Related]

  • 56. Angiotensin-receptor blocker approved as antihypertensive.
    Am J Health Syst Pharm; 1995 Jul 01; 52(13):1368, 1373. PubMed ID: 7671033
    [No Abstract] [Full Text] [Related]

  • 57. Transposition of the imidazole ring substituents of angiotensin mimetics related to Losartan.
    Smith JR, Wahhab A, Moore D, Ganter RC, Moore GJ.
    Drug Des Discov; 1994 Nov 01; 12(2):113-9. PubMed ID: 9116166
    [Abstract] [Full Text] [Related]

  • 58. [Prospects for pharmacological effects on renin-angiotensin and sympathetic nervous systems in patients with arterial hypertension].
    Chikhladze NM.
    Ter Arkh; 2000 Nov 01; 72(12):67-9. PubMed ID: 11201840
    [No Abstract] [Full Text] [Related]

  • 59. Postrenal transplant erythrosis: a direct role for angiotensin II.
    Ducloux D, Fournier V, Chalopin JM.
    Clin Nephrol; 1997 Apr 01; 47(4):277-8. PubMed ID: 9128800
    [No Abstract] [Full Text] [Related]

  • 60. [Nonpeptide angiotensin II antagonists].
    Shionoiri H, Takasaki I, Sugimoto K, Minamisawa K.
    Nihon Rinsho; 1992 Apr 01; 50 Suppl():753-63. PubMed ID: 1635263
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.